Manish A. Shah
@mdmanishshah
Followers
2K
Following
9K
Media
368
Statuses
4K
Father, husband, oncologist @MeyerCancer, researcher. Things we do matter! Chief Solid Tumor Service @WeillCornell @NYPhospital @ASCO FASCO CPGC #GICancers
Between here and there...
Joined March 2014
This also applies when talking to patients @patient - this is often the diff b/t a good doc and #greatdoc @nyphospital @MeyerCancer
2
6
33
Amazing things are happening @WCMDeptofMed @NYHospitals @WCMGIcancer @drallysonocean @DrDespina123 @rutikamehtaMD
podcasts.apple.com
Podcast Episode · CancerCast · 08/04/2025 · 1 sec
Sneak peek: From buzzwords to breakthroughs, Dr. Sarah Rutherford (@DrSarahRuth) & I discuss impactful #cancer research in our @ASCO #CancerCast #Podcast. Get the latest on targeted therapies, circulating tumor DNA/#MRD testing, minimizing toxicity & more.
0
3
7
Sneak peek: From buzzwords to breakthroughs, Dr. Sarah Rutherford (@DrSarahRuth) & I discuss impactful #cancer research in our @ASCO #CancerCast #Podcast. Get the latest on targeted therapies, circulating tumor DNA/#MRD testing, minimizing toxicity & more.
0
12
6
RT @DrDespina123: 🚀 Kicking off our T cell isolation & culture efforts from #pancreatic tumors! Big thanks to @STEMCELLTech for a great dem….
0
1
0
Honored to host CancerCast for @WeillCornell .There is so much to learn and so much to talk about! .Available on Apple Podcast, Spotify, or wherever you listen to podcasts! .
🚨Big news! I’m honored to take over as host for @WeillCornell #CancerCast #podcast. @JohnPLeonardMD and I discussed this transition, reflected on #cancer advances and previewed what’s next, incl. innovative hot topics we’ll explore in future episodes �️.
2
12
20
🚨Big news! I’m honored to take over as host for @WeillCornell #CancerCast #podcast. @JohnPLeonardMD and I discussed this transition, reflected on #cancer advances and previewed what’s next, incl. innovative hot topics we’ll explore in future episodes �️.
podcasts.apple.com
Podcast Episode · CancerCast · 06/23/2025 · 1 sec
0
0
8
RT @christinemphmd: Learn the language of somatic mutations w/ @John_Will_I_Am at @WCMDeptofMed Grand Rounds! @WCMHemOncFellow .@nyphospita….
0
5
0
RT @christinemphmd: New York ➡️ Chicago! Excited to see some of our @WeillCornell @NYPHospital team members at #ASCO25, ready to connect a….
0
10
0
RT @DrDespina123: Building on #theranostics for #pNETs—our latest @Nature_NPJ article dives into innovations in #PRRT, SSTR2 antagonists, &….
0
6
0
RT @rutikamehtaMD: Wondering how to prioritize treatment options in double positive GEAs? Watch @mdmanishshah and me talk about this 👇.http….
vumedi.com
A video from Rutika Mehta and Manish A. Shah (as part of Weill Cornell Medicine Oncology & Hematology), posted on May 15, 2025.
0
5
0
My dear friend, @LizzySmyth1 is up for Director of Education @myESMO - I know of no one better!! . Kudos and great job! Please vote… FOR HER! . #esmo @drallysonocean @DrDespina123 @rutikamehtaMD.
0
3
12
Amazing meeting @ASCO #GIASCO and really nice to help provide updates for @eChinaHealth . @WeillCornell @WCM_GI @nyphospital.
25,273 Chinese physicians and professionals joined virtually for the “New Progress in Advanced Gastric Cancer - Featuring Licensed Content from ASCO.” A heartfelt thank you to all the incredible speakers for making this event a success!.@mdmanishshah @KoheiShitara .@WeillCornell
0
1
10
RT @eChinaHealth: 25,273 Chinese physicians and professionals joined virtually for the “New Progress in Advanced Gastric Cancer - Featuring….
0
1
0
Nice job Sam!.
0
0
4
RT @DAVAOnc: Who wore it best? A fantastic group of oncology leaders at the #DAVAGI summit discussing the future of cancer care! @vinaykjai….
0
3
0
RT @AndresC27622123: Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy - @Annals_Oncolog….
0
9
0
RT @stolaney1: Real-world assessment of TDXd-related ILD. 67/600 pts developed ILD (central adjudication).Median time to onset-- cycle 7, 8….
0
43
0
RT @ILSONDavid: Niche 2 after two doses of nivolumab and one dose of ipi and surgery. 100% of patients with MSI high colon cancer relapse f….
0
21
0
RT @ArndtVogel: FOLFIRI plus ramucirumab vs FOLFOXIRI plus RAM as 1L treatment for mCRC.#ESMO24.🔎RECAST phs 2, 122. pts, .👉ORR 60 vs 60%.👉m….
0
25
0
RT @ArndtVogel: Pembrolizumab + CAPOX /bevacizumab in MSS CRC and a high immune infiltrate #ESMO24 .🔎POCHI trial.👉ORR 74%, DRC 100%, 5 CR.👉….
0
51
0